Anesthetic Management for Cesarean Delivery in a Pregnant Patient With Spinal Muscular Atrophy Type 2: A Case Report. [PDF]
Lopez Saenz JG +3 more
europepmc +1 more source
T cells, the Next Big Target in Axial Spondyloarthritis?
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterized by complex immune dysregulation, with T cells playing a central role in its pathogenesis. In this review, we synthesize current knowledge on diverse T cell subsets in axSpA, their pathogenic mechanisms, and emerging therapeutic strategies targeting these cells. We highlight
Mansi K. Aparnathi, Nigil Haroon
wiley +1 more source
Anesthetic Management in a Patient With Tethered Spinal Cord Syndrome Undergoing Knee Replacement Surgery. [PDF]
Alessi L +7 more
europepmc +1 more source
Objective Axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) are overlapping yet distinct conditions within the SpA spectrum. As divergent immunophenotypes may influence disease course and therapeutic response, we compared immune cell subsets, cytokine profiles, and inflammatory mediators.
Natalie Frede +11 more
wiley +1 more source
Several key issues should be emphasized in assessing clinical benefits of a regional block for elderly patients undergoing hip arthroplasty under spinal anesthesia. [PDF]
Li RP, Xue FS, Cheng Y.
europepmc +1 more source
Objective To assess the efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with psoriatic arthritis (PsA) who were naive to biologic disease‐modifying antirheumatic drugs or received tumor necrosis factor inhibitors. Methods In the 52‐week (W), double‐blind, placebo‐controlled, phase 3 POETYK PsA‐2 study
Philip J. Mease +20 more
wiley +1 more source
Predictive modeling of labor epidural catheter replacement or conversion to spinal or general anesthesia: a multicenter retrospective cohort study (2017-2024). [PDF]
Berenson DF +5 more
europepmc +1 more source
PANTOCAIN IN SPINAL ANESTHESIA
D C, Bull, C B, Esselstyn
openaire +3 more sources
Objectives To evaluate the impact of bimekizumab, a dual IL‐17A and IL‐17F inhibitor, on sacroiliac joint (SIJ) and spine inflammation/structural damage in axSpA using MRIs/radiographs from the phase 3 studies BE MOBILE 1 (nr‐axSpA) and 2 (r‐axSpA) and their open‐label extension (OLE).
Walter P. Maksymowych +10 more
wiley +1 more source
An anesthesia-integrated model for predicting postoperative urinary retention after transurethral resection of the prostate: A retrospective cohort study. [PDF]
Zhu P, Yang Y.
europepmc +1 more source

